<unk>  (INN, USAN) was an experimental antiplatelet drug acting as a P2Y12 inhibitor. Similarly to ticagrelor and in contrast to clopidogrel,<unk>  was a reversible inhibitor that acted fast and short (for about 12 hours), and it was not a prodrug but pharmacologically active itself. The substance was used in form of its potassium salt, intravenously for acute treatment and orally for long-term treatment. Development was terminated in 2012.
Elinogrel
Eptifibatide
Prasugrel
Apixaban
Oprelvekin
Dabigatran
Ticagrelor
Epitiostanol